Products with Antioxidants bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN2829 | Demethyleneberberine |
| 1. Demethyleneberberine, which is composed of a potential antioxidant structure, could penetrate the membrane of mitochondria and accumulate in mitochondria either in vitro or in vivo. 2. Demethyleneberberine suppresses CYP2E1, hypoxia inducible factor α, and inducible nitric oxide synthase, which contributes to oxidative stress and restored sirtuin 1/AMP-activated protein kinase/peroxisome proliferator-activated receptor-γ coactivator-1α pathway-associated fatty acid oxidation in chronic ethanol-fed mice. | |
| BCN2830 | Kaempferol-3-O-glucorhamnoside |
| 1. Kaempferol-3-O-glucorhamnoside exhibits significant antioxidant activity by scavenging stable DPPH free radicals. | |
| BCN2840 | Liguiritigenin-7-O-D-apiosyl-4'-O-D-glucoside |
| Liquiritin apioside has antioxidant property by inducing glutathione (GSH) biosynthesis via the inhibition of cytokines and protected lung epithelial cells against cigarette smoke-mediated oxidative stress, might be as protective agent against epithelial injury in COPD. | |
| BCN2849 | 7-O-Methylaloeresin A |
| 1. 7-O-Methylaloeresin A has moderate inhibitory active on BACE. 2. 7-O-Methylaloeresin A shows significant antioxidant activity. 3. 7-O-Methylaloeresin A exhibits good activity against multiple drug resistant Staphylococcus aureus (NCTC 11994) and Salmonella typhimurium (ATCC 1255) with MIC values of 0.72 and 0.18 mm, respectively. | |
| BCN2851 | Quercetin 3-O-beta-D-xylopyranoside |
| 1. Quercetin derivatives can be practically applied for the treatment and prevention of osteoporosis, since they effectively inhibit osteoclast proliferation and stimulate osteoblast proliferation more than conventional therapeutic agents for osteoporosis, and increase trabecular bone area highly without changing hormone level in body and untoward effects on hematopoietic function and immune system. | |
